Literature DB >> 2147664

Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome.

O H Nielsen1, K Hvid-Jacobsen, P Lund, E Langholz.   

Abstract

Thirty-seven consecutive patients referred to a regional gastroenterology outpatient clinic with complaints of persistent nausea had a double isotopic scintigraphic evaluation of solid and liquid gastric emptying. Gastric emptying of both forms followed an exponential model. Marked day to day variation of gastric emptying was noted with a coefficient of variation of approximately 0.20 for both phases. Only 9 of 37 patients had delayed gastric emptying rate of the solid component (greater than 180 min) and no correlation between gastric stasis syndrome and nausea was established. Among these patients the median time for the stomach to empty 50% of the solid component was 261 min and 50% of the liquid component was 66 min. Treatment of these 9 patients shown to have gastric stasis syndrome and further 3 patients with diabetic gastroparesis with ondansetron, a highly selective antagonist of 5-hydroxytryptamine-3-receptors, resulted in a gastric emptying rate which was not statistically faster than after placebo (p = 0.11).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147664     DOI: 10.1159/000200337

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

Review 1.  Receptors of the enteric nervous system: potential targets for drug therapy.

Authors:  J Tack
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Unexplained Nausea and Vomiting.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 3.  Gastroparesis: current diagnostic challenges and management considerations.

Authors:  Shamaila Waseem; Baharak Moshiree; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 4.  A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Authors:  Zhou Likun; Jing Xiang; Ba Yi; Duan Xin; Zheng Liu Tao
Journal:  Oncologist       Date:  2011-01-31

Review 5.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.

Authors:  Kellie Simmons; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2014-03-11       Impact factor: 3.199

Review 7.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

8.  Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.

Authors:  Deena Midani; Henry P Parkman
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

9.  Recent advances in the pathophysiology and treatment of gastroparesis.

Authors:  Jung Hwan Oh; Pankaj J Pasricha
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.